• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

分子影像与放射治疗：个体化患者管理的治疗诊断学。

Molecular imaging and radiotherapy: theranostics for personalized patient management.

机构信息

PET-Centre, Centre for Medical Imaging, Uppsala University Hospital, SE-751 85 Uppsala, Sweden.

出版信息

Theranostics. 2012;2(5):424-6. doi: 10.7150/thno.4428. Epub 2012 May 1.

DOI:10.7150/thno.4428
PMID:22768022
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3360195/
Abstract

This theme issue presents current achievements in the development of radioactive agents, pre-clinical and clinical molecular imaging, and radiotherapy in the context of theranostics in the field of oncology.

摘要

本期专刊介绍了放射性药物、临床前和临床分子影像学以及肿瘤治疗学领域的放射性治疗的最新发展成果。

相似文献

1
Molecular imaging and radiotherapy: theranostics for personalized patient management.分子影像与放射治疗：个体化患者管理的治疗诊断学。
Theranostics. 2012;2(5):424-6. doi: 10.7150/thno.4428. Epub 2012 May 1.
2
Theranostics in Nuclear Medicine: Emerging and Re-emerging Integrated Imaging and Therapies in the Era of Precision Oncology.核医学中的治疗学：精准肿瘤学时代新兴和再现的综合影像与治疗
Radiographics. 2020 Oct;40(6):1715-1740. doi: 10.1148/rg.2020200021.
3
[Nuclear medicine diagnostics, therapy and theranostics in the context of modern oncology].现代肿瘤学背景下的核医学诊断、治疗与诊疗一体化
Ther Umsch. 2019 Sep;76(4):167-172. doi: 10.1024/0040-5930/a001080.
4
THERANOSTICS: From Molecular Imaging Using Ga-68 Labeled Tracers and PET/CT to Personalized Radionuclide Therapy - The Bad Berka Experience.治疗学：从使用 Ga-68 标记示踪剂的分子成像到 PET/CT 以及个体化放射性核素治疗——Bad Berka 的经验。
Theranostics. 2012;2(5):437-47. doi: 10.7150/thno.3645. Epub 2012 May 7.
5
(Radio)Theranostic Patient Management in Oncology Exemplified by Neuroendocrine Neoplasms, Prostate Cancer, and Breast Cancer.以神经内分泌肿瘤、前列腺癌和乳腺癌为例的肿瘤放射治疗诊断患者管理
Pharmaceuticals (Basel). 2020 Mar 5;13(3):39. doi: 10.3390/ph13030039.
6
Current Status of Theranostics in Jordan.约旦治疗诊断学的现状。
Nucl Med Mol Imaging. 2019 Feb;53(1):7-10. doi: 10.1007/s13139-018-0562-5. Epub 2018 Dec 11.
7
Theranostics in nuclear medicine practice.核医学实践中的诊疗一体化
Onco Targets Ther. 2017 Oct 3;10:4821-4828. doi: 10.2147/OTT.S140671. eCollection 2017.
8
Role of theranostics in thoracic oncology.诊疗一体化在胸部肿瘤学中的作用。
J Thorac Dis. 2020 Sep;12(9):5140-5146. doi: 10.21037/jtd-2019-pitd-13.
9
Perspectives in Radiomics for Personalized Medicine and Theranostics.个性化医疗与治疗诊断学中的放射组学展望
Nucl Med Mol Imaging. 2019 Jun;53(3):164-166. doi: 10.1007/s13139-019-00578-x. Epub 2019 Jan 23.
10
The Current Status and Future Potential of Theranostics to Diagnose and Treat Childhood Cancer.用于诊断和治疗儿童癌症的诊疗一体化技术的现状与未来潜力
Front Oncol. 2020 Nov 19;10:578286. doi: 10.3389/fonc.2020.578286. eCollection 2020.

引用本文的文献

1
Metal-Ligand Interactions in Scandium Complexes with Radiopharmaceutical Applications.具有放射性药物应用的钪配合物中的金属-配体相互作用
Inorg Chem. 2023 Dec 18;62(50):20733-20744. doi: 10.1021/acs.inorgchem.3c02211. Epub 2023 Nov 10.
2
First In Vivo and Phantom Imaging of Cyclotron-Produced La as a Theranostic Radionuclide for Ac and La.回旋加速器生产的镧作为放射性核素用于 Ac 和 La 的治疗诊断的首例体内和体模成像。
J Nucl Med. 2022 Apr;63(4):584-590. doi: 10.2967/jnumed.121.262459. Epub 2021 Aug 12.
3
A combination of surgery, theranostics, and liquid biopsy - a personalised oncologic approach to treatment of patients with advanced metastatic neuroendocrine neoplasms.手术、治疗学和液体活检的联合应用——一种针对晚期转移性神经内分泌肿瘤患者的个体化肿瘤治疗方法。
Int J Med Sci. 2021 Mar 19;18(10):2166-2175. doi: 10.7150/ijms.51740. eCollection 2021.
4
Microfluidics-Coupled Radioluminescence Microscopy for Radiotracer Kinetic Studies.微流控耦合放射光显微镜用于放射性示踪动力学研究。
Anal Chem. 2021 Mar 16;93(10):4425-4433. doi: 10.1021/acs.analchem.0c04321. Epub 2021 Mar 1.
5
High yield cyclotron production of a novel La theranostic pair for nuclear medicine.高产回旋加速器生产新型镧放射性药物用于核医学
Sci Rep. 2020 Dec 17;10(1):22203. doi: 10.1038/s41598-020-79198-x.
6
High-Efficiency Production of Radiopharmaceuticals via Droplet Radiochemistry: A Review of Recent Progress.通过液滴放射化学实现放射性药物的高效生产：近期进展综述。
Mol Imaging. 2020 Jan-Dec;19:1536012120973099. doi: 10.1177/1536012120973099.
7
Anticancer Ruthenium(III) Complexes and Ru(III)-Containing Nanoformulations: An Update on the Mechanism of Action and Biological Activity.抗癌钌（III）配合物及含钌（III）纳米制剂：作用机制与生物活性的最新进展
Pharmaceuticals (Basel). 2019 Sep 26;12(4):146. doi: 10.3390/ph12040146.
8
Intratumoral F-FLT infusion in metabolic targeted radiotherapy.代谢靶向放疗中的瘤内F-FLT注入
EJNMMI Res. 2019 Apr 11;9(1):33. doi: 10.1186/s13550-019-0496-7.
9
Prospective of Ga Radionuclide Contribution to the Development of Imaging Agents for Infection and Inflammation.镓放射性核素在感染和炎症显像剂发展中的应用前景。
Contrast Media Mol Imaging. 2018 Jan 4;2018:9713691. doi: 10.1155/2018/9713691. eCollection 2018.
10
Sc as useful β-emitter for the radiotheragnostic paradigm: a comparative study of feasible production routes.钪作为放射诊断模式中有用的β发射体：可行生产路线的比较研究。
EJNMMI Radiopharm Chem. 2017;2(1):5. doi: 10.1186/s41181-017-0024-x. Epub 2017 Jun 2.

本文引用的文献

1
Lessons on Tumour Response: Imaging during Therapy with (177)Lu-DOTA-octreotate. A Case Report on a Patient with a Large Volume of Poorly Differentiated Neuroendocrine Carcinoma.肿瘤反应评估中的教训：（177）Lu-DOTA-奥曲肽治疗期间的影像学。一例大体积低分化神经内分泌癌患者的病例报告。
Theranostics. 2012;2(5):459-71. doi: 10.7150/thno.3594. Epub 2012 May 9.
2
Molecular Imaging Radiotherapy: Theranostics for Personalized Patient Management of Neuroendocrine Tumors (NETs).分子影像放疗：神经内分泌肿瘤（NETs）个性化患者管理的诊疗一体化
Theranostics. 2012;2(5):448-58. doi: 10.7150/thno.3931. Epub 2012 May 8.
3
THERANOSTICS: From Molecular Imaging Using Ga-68 Labeled Tracers and PET/CT to Personalized Radionuclide Therapy - The Bad Berka Experience.治疗学：从使用 Ga-68 标记示踪剂的分子成像到 PET/CT 以及个体化放射性核素治疗——Bad Berka 的经验。
Theranostics. 2012;2(5):437-47. doi: 10.7150/thno.3645. Epub 2012 May 7.
4
How Does the Patient Benefit from Clinical PET?患者如何从临床 PET 中获益？
Theranostics. 2012;2(5):427-36. doi: 10.7150/thno.3794. Epub 2012 May 4.
5
Pretargeted molecular imaging and radioimmunotherapy.靶向分子影像学与放射性免疫治疗。
Theranostics. 2012;2(5):523-40. doi: 10.7150/thno.3582. Epub 2012 May 17.
6
Imaging of adrenal masses with emphasis on adrenocortical tumors.肾上腺肿块的影像学表现，重点是肾上腺皮质肿瘤。
Theranostics. 2012;2(5):516-22. doi: 10.7150/thno.3613. Epub 2012 May 17.
7
Imaging key biomarkers of tumor angiogenesis.肿瘤血管生成的影像学关键生物标志物。
Theranostics. 2012;2(5):502-15. doi: 10.7150/thno.3623. Epub 2012 May 17.
8
Radiolabeled peptides: valuable tools for the detection and treatment of cancer.放射性标记肽：用于癌症检测和治疗的宝贵工具。
Theranostics. 2012;2(5):481-501. doi: 10.7150/thno.4024. Epub 2012 May 16.
9
Long-Term Survival, Toxicity Profile, and role of F-18 FDG PET/CT scan in Patients with Progressive Neuroendocrine Tumors Following Peptide Receptor Radionuclide Therapy with High Activity In-111 Pentetreotide.高活性铟-111 喷曲肽肽受体放射性核素治疗后进展性神经内分泌肿瘤患者的长期生存、毒性特征及 F-18 FDG PET/CT 扫描的作用
Theranostics. 2012;2(5):472-80. doi: 10.7150/thno.3739. Epub 2012 May 11.